Skip to main content
letter
. 2023 Apr 27;36(4):421–424. doi: 10.37201/req/132.2022

Table 1.

Risk factors and clinical characteristics of Nocardia COVID-19 coinfected patients.

Author (year) [reference] Sex & Age Risk factors Days after COVID-19 diagnosis Clinical picture CT scan features
Colaneri (2021) [6] Woman, 45 years Untreated HIV/HCV IDU
5 days
Fever, coughing, dyspnea, fatigability (10 days). Oxygen saturation at room air: 94% Multiple necrotic core lesions in both lungs, kidneys and soft tissues with peripheral contrast enhancement
Laplace (2021) [7] Male, 86 years Type 2 DM, COPD,
Crohn´s disease

13 days
Acute dyspnea, fever, productive cough Dense consolidation with air bronchograms in lower lung lobes

Atemnkeng (2021) [8]

Male, 63 years

Morbid obesity, Type 2 DM


32 days

Worsening shortness of breath. Oxygen saturation at room air: 77%
Near-complete opacification of the left hemithorax with minimal sparing of the apical region
MRI: multiple bilateral ring- enhancing lesions in the brain
Arif (2021) [9] Woman, 61 years Type 2 DM, hypertension, HF
10 days

Dyspnea
Right upper lobe 3.3 x 3.2 cm mass and a left upper lobe 1.9 x 1.5 cm nodule
Driscoll (2022) [10] Male, 16 years Bronchiectasis Pseudomonas aeruginosa infection
6 days

Fever, dyspnea, cough, and lethargy
Left lower lobe opacification but no necrosis or pulmonary embolus
Ortiz (2023) [Present case] Male, 86 years Type 2 DM, hypertension, myeloma, COPD, atrial flutter, CKD
11 days
Increased productive cough, dyspnea Oxygen saturation at room air: 82% Multifocal and bilateral cavitated condensations. Ground glass pattern areas and distal bronchial thickening

Type 2 DM: type 2 diabetes mellitus. COPD: Chronic obstructive pulmonary disease. CKD: Chronic kidney disease. HF: heart failure. HIV/HCV: chronic hepatitis C virus & HIV coinfected. IDU: Injecting drug user. SLE: Systemic lupus erythematosus.